Journal article

Reintervention and Survival After Limited Lung Resection for Lung Cancer Treatment in Australia

Bich Tran, Art Sedrakyan, Peter Flynn, Nasser Altorki, Louisa Jorm, Gavin Wright

The Annals of Thoracic Surgery | ELSEVIER SCIENCE INC | Published : 2019


BACKGROUND: To investigate the risk and predictors of reintervention (surgery or radiotherapy) after limited resection for lung cancer. METHODS: A population-based, all-inclusive study using linked data from the New South Wales Admitted Patient Data Collection and Death Register included all patients undergoing limited resection for lung cancer between July 1, 2002, and March 31, 2014. Univariate and adjusted competing risk analyses were used to estimate the effect of potential factors for risk of reintervention within 6 months and 24 months of the initial surgery. RESULTS: The overall 5-year survival for lung cancer patients undergoing limited lung resection was 52% (49% to 54%); for patien..

View full abstract


Awarded by National Health and Medical Research Council Project Grant

Funding Acknowledgements

The authors wish to acknowledge the NSWMinistry ofHealth and NSWRegister of Births, Deaths, and Marriages for allowing access to the data, and the Center for Health Record Linkage for conducting the probabilistic linkage of records. They would like to thank Dr Michael Falster and Dr Marina Van Leeuwen for providing advice and expertise in the use and analysis of the Admitted Patients Data Collection data. They also thank Dr Deborah Randall for her prior work on the Indigenous Health Outcomes Patient Evaluation (IHOPE) data. They would like to thank the IHOPE study reference group for their feedback and interpretation of the study findings. The IHOPE study is funded by a National Health and Medical Research Council Project Grant (#573113). The funding body has no role in the research project. Gavin Wright is supported to build research collaborations by the Research and Education Lead Program of the Strategic Research Plan of the Victorian Comprehensive Cancer Center. Approval for the study was given by the NSW Population and Health Services Research Ethics Committee, the Aboriginal Health and Medical Research Council of NSWEthics Committee, and the University of Western Sydney Human Research Ethics Committee.